Traders should monitor voting outcomes and potential regulatory approvals, as failure to secure stockholder approval could derail the deal. The lack of disclosed financial terms in this communication suggests referencing the S-4 proxy statement for deal specifics.
Price Chart
Executive Summary
Penumbra Inc sent a letter to its stockholders urging them to vote in favor of the proposed acquisition by Boston Scientific Corporation, with the special meeting scheduled for May 6, 2026. The board unanimously recommends approval.
Key Financial Metrics
Key Facts
- Penumbra's board unanimously recommends stockholders vote FOR the merger with Boston Scientific.
- Special meeting to vote on the merger is scheduled for May 6, 2026.
- Failing to vote has the same effect as voting against the merger.
- The proxy statement/prospectus was declared effective on April 1, 2026.
- This filing is a Rule 425 communication, part of the merger solicitation process.
Financial Impact
Potential acquisition of Penumbra Inc by Boston Scientific, though specific deal value and terms are not disclosed in this filing.
Risk Factors
- Risk that the merger fails to obtain required stockholder approval.
- Potential for regulatory delays or opposition to the acquisition.
- Market uncertainty until the special meeting vote on May 6, 2026.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 425 Filing (Primary) | 0000950103-26-005882 |
| Document: 0000950103-26-005882-index-headers.html | 0000950103-26-005882 |
| Document: 0000950103-26-005882-index.html | 0000950103-26-005882 |
| Document: 0000950103-26-005882.txt | 0000950103-26-005882 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Jul 30, 2026 9w ago | Press Release | $321.19 $321.68 | ▼ −0.15% | ▲ +2.84% | $317.55 (+1.13%) |
May 7, 2026 21w ago | 425 | $324.65 $319.37 | ▼ −1.63% | ▼ −4.76% | $317.55 (−2.19%) |
May 6, 2026 21w ago | 8-K | $324.65 $319.37 | ▲ +1.63% | ▲ +4.76% | $317.55 (+2.19%) |
Apr 29, 2026 22w ago | DEFA14A | $326.48 $318.30 | ▼ −2.51% | ▼ −7.73% | $317.55 (−2.74%) |
Apr 17, 2026 24w ago | 425 | $329.71 $326.54 | ▼ −0.96% | ▼ −5.16% | $317.55 (−3.69%) |
Apr 1, 2026 26w ago | DEFM14A | $330.36 $326.48 | ▼ −1.17% | ▼ −11.05% | $317.55 (−3.88%) |
Feb 25, 2026 31w ago | 8-K | $338.67 $336.27 | ▼ −0.71% | ▲ +4.53% | $317.55 (−6.24%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access